625471-04-7 Usage
Uses
Used in Pharmaceutical Industry:
tert-butyl (3S)-3-aMinoazepane-1-carboxylate is used as a key intermediate in the synthesis of ureidothiophenes, which are a class of compounds with significant potential as CHK1 kinase inhibitors. CHK1 kinase is a crucial enzyme involved in the regulation of cell cycle progression, and its inhibition has been shown to have therapeutic benefits in the treatment of various types of cancer, particularly solid tumors.
As a CHK1 kinase inhibitor, tert-butyl (3S)-3-aMinoazepane-1-carboxylate plays a vital role in the development of novel anticancer drugs that can effectively target and inhibit the growth of cancer cells. This makes it a promising candidate for use in the pharmaceutical industry, where it can contribute to the advancement of cancer treatment options and improve patient outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 625471-04-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,5,4,7 and 1 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 625471-04:
(8*6)+(7*2)+(6*5)+(5*4)+(4*7)+(3*1)+(2*0)+(1*4)=147
147 % 10 = 7
So 625471-04-7 is a valid CAS Registry Number.
625471-04-7Relevant academic research and scientific papers
SUBSTITUTED HETEROCYCLES AND THE USES THEREOF
-
Page/Page column 55-26, (2010/02/12)
This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
